X0306 4 2020-09-29 1 0001699382 PMV Pharmaceuticals, Inc. PMVP 0001712922 Nextech V Oncology S.C.S., SICAV-SIF 8 RUE LOU HEMMER SENNINGERBERG, LUXEMBOURG N4 L-1748 LUXEMBOURG 0 0 0 1 Former 10% Owner 0001826326 NEXTECH V GP S.A R.L. 8 RUE LOU HEMMER SENNINGERBERG, LUXEMBOURG N4 N4 L-1748 LUXEMBOURG 0 0 0 1 Former 10% Owner 0001826431 Bleyer Dalia 8 RUE LOU HEMMER SENNINGERBERG, LUXEMBOURG N4 N4 L-1748 LUXEMBOURG 0 0 0 1 Former 10% Owner 0001826413 Lips Thomas 8 RUE LOU HEMMER SENNINGERBERG, LUXEMBOURG N4 N4 L-1748 LUXEMBOURG 0 0 0 1 Former 10% Owner 0001826386 Detournay Philippe 8 RUE LOU HEMMER SENNINGERBERG, LUXEMBOURG N4 N4 L-1748 LUXEMBOURG 0 0 0 1 Former 10% Owner Common Stock 2020-09-29 4 C 0 1768023 A 1768023 D Common Stock 2020-09-29 4 C 0 760267 A 2528290 D Series C Preferred Stock 2020-09-29 4 C 0 1768023 0.00 D Common Stock 1768023 0 D Series D Preferred Stock 2020-09-29 4 C 0 760267 0.00 D Common Stock 760267 0 D The shares of each of the Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date. The shares are held of record by Nextech V Oncology S.C.S., SICAV-SIF. Thilo Schroeder is a partner at Nextech Invest AG and in the Investment Committee of Nextech Invest AG, with significant influence over Nextech V Oncology S.C.S., SICAV-SIF in terms of investment decisions, selling strategy of shares and voting power and as a result, may be deemed to have beneficial ownership over such securities. Mr. Schroeder is a director of the Issuer and files separate Section 16 reports. Nextech V GP S.a r.l. is the general partner of Nextech V Oncology S.C.S., SICAV SIF. Dalia Bleyer, Philippe Detournay and Thomas Lips are Managers of Nextech V GP S.a r.l. and each of Nextech V GP S.a r.l., Ms. Bleyer and Messrs. Detournay and Lips may be deemed to share voting and investment power with respect to the shares reported herein and disclaim beneficial ownership over such shares, except to the extent of his, her or its respective pecuniary interest therein, if any. Nextech V Oncology S.C.S., SICAV-SIF, By: /s/ Dalia Bleyer and /s/ Philippe Detournay, Managers of Nextech V GP S.a r.l., its General Partner 2020-09-29 NEXTECH V GP S.A R.L., By: /s/ Dalia Bleyer and /s/ Philippe Detournay, Managers 2020-09-29 /s/ Dalia Bleyer 2020-09-29 /s/ Thomas Lips 2020-09-29 /s/ Philippe Detournay 2020-09-29